Snowball logo
logo
COR_logo

Cencora, Inc.

$310.80-$3.37ย  (1.07%)
COR's revenue surged to approximately $321 billion...
View AAPL example
Estimate
P/E
23.4
EPS
13.27
Beta
0.573
Growth
Revenue, YoY
5.07%
Net income, YoY
11.07%
FCF, YoY
3,382.48%
Forecast
P/E (FWD)
15.7
EPS (FWD)
19.831
Dividends
Dividend yield
0.77%
Annual payout
$2.40
Next ex. div date
August 14, 26
Payout
17.83%
Div.growth, 5y
6.16%
Dividend growth streak
21 y
Div.rating
About the company
Ticker
COR
ISIN
US03073E1055
Country
United States of America
Sector (GICS)
Healthcare
Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, and other specialty pharmaceutical products; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; sales force services to manufacturers; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.

Frequently asked questions

What sector does Cencora, Inc. (COR) operate in?

Cencora, Inc. belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is Cencora, Inc. (COR) current stock price?

As of the latest data, Cencora, Inc. stock price is $310.80, with a previous close of $314.17. Cencora, Inc. lost -$3.37 in the last trading session, representing a -1.07% loss.

What is Cencora, Inc. (COR) current market capitalization?

Cencora, Inc. market cap is approximately 59.31 billion.

What is Cencora, Inc. (COR) Earnings Per Share (EPS)?

The trailing EPS is $13.27, and the forward EPS is $19.83.

What is Cencora, Inc. (COR) Price-to-Earnings (P/E) ratio?

Cencora, Inc. current P/E ratio is 23.42, with a forward P/E of 15.67.

What is Cencora, Inc. (COR) EBITDA?

Cencora, Inc. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.41 billion.

Does Cencora, Inc. (COR) pay dividends?

Yes. Cencora, Inc. pays quarterly dividends with an annualized yield of 0.77% and an estimated annual payout of $2.40 per share.

When is the next ex-dividend date for Cencora, Inc. (COR)?

The next ex-dividend date is scheduled for August 14, 2026.

How did Cencora, Inc. (COR) perform in its most recent earnings report?

In the last report (June 30, 2026), Cencora, Inc. posted an EPS surprise of 2.52% and a revenue surprise of 0.72%.

What is Cencora, Inc. (COR) beta (volatility) score?

Cencora, Inc. has a beta of 0.573, indicating lower volatility than the overall market.